The event witnessed innovative exchange of thoughts with an aim to create an efficient IP framework globally to bolster the potential of growth, investments, and collaboration amid crises.
India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference
More from Industry NewsMore posts in Industry News »
- StayHappi pharmacy enters Assam with 70 stores
- Mumbai: Larger ITAT bench to rule on pharma freebies
- India to procure over 30 crore Covid-19 vaccine doses per month by January: Government sources
- Drug companies eye mRNA technology for flu shots
- Pharma Corporation Haffkine’s rollout of Covaxin not likely till May